Summary
A new Biovigilance Programme was approved to monitor safety of medicines and biological products used in organ and tissue transplants.
The 2026 National Formulary contains 34 chapters, 20 appendices and detailed information on 653 medicines.
A mobile application called Adverse Drug Reaction – Pharmacovigilance Programme of India 2.0 helps health workers report medicine side‑effects.
India’s contribution to the World Health Organization’s patient safety database has risen from 123rd to eighth globally.
Digital tools such as online formularies and data‑analytics platforms are being promoted to improve medicine‑safety monitoring.
A new Biovigilance Programme was approved to monitor safety of medicines and biological products used in organ and tissue transplants.
Want to learn even more? Click here to read the full story!